|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.474
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.444
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.376
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.364
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.342
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.341
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.317
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.287
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.284
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.281
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.273
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.229
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.229
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.214
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.211
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.204
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.200
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.199
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.185
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.183
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.177
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.170
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.169
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.169
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.164
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.162
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.158
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.155
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.154
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.146
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.146
|
|
|
|
spinal cord ventral commissure morphogenesis
|
GO:0021965 |
2 |
0.143
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.143
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.143
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.142
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.140
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.137
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.134
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.134
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.133
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.132
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.130
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.128
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.126
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.126
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.123
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.121
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.117
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.115
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.115
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.115
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.115
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.113
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.110
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.110
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.110
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.110
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.109
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.103
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.102
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.102
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.101
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.099
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.098
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.098
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.097
|
|
|
|
recognition of apoptotic cell
|
GO:0043654 |
3 |
0.097
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.096
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.096
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.096
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.094
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.093
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.092
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.089
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.089
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.088
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.087
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.086
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.086
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.085
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.085
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.084
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.084
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.083
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.083
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.083
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.082
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.081
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.080
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.080
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.079
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.079
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.079
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.079
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.079
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.079
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.078
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.078
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.077
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.077
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.076
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.075
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.075
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.075
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.075
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.074
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.074
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.073
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.071
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.071
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.070
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.070
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.069
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.069
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.068
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.068
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.068
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.068
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.067
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.067
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.067
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.066
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.065
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.065
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.065
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.065
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.064
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.064
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.064
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.064
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.064
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.064
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.063
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.063
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.061
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.061
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.061
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.061
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.061
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.061
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.061
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.060
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.060
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.060
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.059
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.059
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.059
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.058
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.058
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.058
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.058
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.058
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.058
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.057
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.056
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.056
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.056
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.056
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.056
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.056
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.056
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.056
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.055
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.055
|
|
|
|
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation
|
GO:0021938 |
4 |
0.055
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.055
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.055
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.054
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.054
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.054
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.054
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.054
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.053
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.053
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.053
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.053
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.052
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.052
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.052
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.052
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.052
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.051
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.051
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.050
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.050
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.050
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.050
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.050
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.049
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.049
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.049
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.049
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.048
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.048
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.047
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.047
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.047
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.047
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.047
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.047
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.047
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.046
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.046
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.046
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.046
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.046
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.046
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.046
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.046
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.046
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.045
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.045
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.045
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.045
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.045
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.045
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.045
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.044
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.044
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.044
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.044
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.044
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.044
|
|
|
|
cell surface receptor signaling pathway involved in heart development
|
GO:0061311 |
15 |
0.043
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.043
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.043
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.043
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.043
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.042
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.042
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.042
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.042
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.042
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.042
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.042
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.042
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.042
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.042
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.041
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.041
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.041
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.041
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.040
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.040
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.040
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.040
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.040
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.040
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.039
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.039
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.039
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.039
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.039
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.039
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.039
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.038
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.038
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.038
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.038
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.038
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.038
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.038
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
11 |
0.038
|
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.038
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.038
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.038
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.038
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.037
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.037
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.037
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.037
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.037
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.037
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.037
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.037
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.037
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.037
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.037
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.037
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.036
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.036
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.036
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.036
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.036
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.036
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.036
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.036
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.036
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.035
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.035
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.035
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.035
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.035
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.035
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.034
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.034
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.034
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.034
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.034
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.033
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.033
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.033
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.033
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.033
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.033
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.033
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.033
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.033
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.033
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.033
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.033
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.033
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.033
|
|
|
|
arterial endothelial cell differentiation
|
GO:0060842 |
5 |
0.032
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.032
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.032
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.032
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.032
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.032
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.032
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.032
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.032
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.032
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.031
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.031
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.031
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.031
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.031
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.031
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.031
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.030
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.030
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.030
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.030
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.030
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.030
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.030
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.030
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.030
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.030
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
11 |
0.030
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.030
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.029
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.029
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.029
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.029
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.029
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.029
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.029
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.029
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.029
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.029
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.029
|
|
|
|
endocardial cushion to mesenchymal transition
|
GO:0090500 |
5 |
0.029
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.029
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.028
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.028
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.028
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.028
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.028
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.028
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.028
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.028
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.028
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.028
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.028
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.028
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.027
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.027
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.027
|
|
|
|
muscular septum morphogenesis
|
GO:0003150 |
4 |
0.027
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.027
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.027
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.027
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.027
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.027
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.026
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.026
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
18 |
0.026
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.026
|
|
|
|
frontal suture morphogenesis
|
GO:0060364 |
2 |
0.026
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.026
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.026
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.026
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.026
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.025
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.025
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.025
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.025
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.025
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.025
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.025
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.025
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.025
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.025
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.025
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.025
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.025
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.025
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.025
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.025
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.025
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.025
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.024
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.024
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.024
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.024
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.024
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.024
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.024
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.024
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.024
|
|
|
|
epithelial to mesenchymal transition involved in endocardial cushion formation
|
GO:0003198 |
10 |
0.024
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.024
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.024
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.024
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.024
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.024
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.024
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.024
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.023
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.023
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.023
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.023
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.023
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.023
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.023
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.023
|
|
|
|
ventral midline development
|
GO:0007418 |
4 |
0.023
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.023
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.023
|
|
|
|
regulation of tongue muscle cell differentiation
|
GO:2001035 |
2 |
0.023
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.023
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.023
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.023
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.023
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.023
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.023
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.023
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.023
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.022
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.022
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.022
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.022
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.022
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.022
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.022
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.022
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.022
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.022
|
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.022
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.022
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.022
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.022
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.022
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.022
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.022
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.022
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.022
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.021
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.021
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.021
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.021
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.021
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.021
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.021
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.021
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.021
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.021
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.021
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.021
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.021
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.021
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.021
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.021
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.021
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.021
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.020
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.020
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.020
|
|
|
|
nephron tubule formation
|
GO:0072079 |
20 |
0.020
|
|
